email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1036 - 1050
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Ablaze Closes $75 Million Series for Targeted Radiopharmaceutical Therapies
$5.00
Available
Help Therapeutics Raises $25 Million for iPSC Heart Failure/Oncology Therapies
$5.00
Available
3D Medicines Approved to Launch Anti-PD-L1 in China
$5.00
Available
Tongshu Biotechnology Raises $78 Million for Early Cancer Screening Tests
$5.00
Available
Neurophth Closes $60 Million C Round for Ophthalmic Gene Therapies
$5.00
Available
BeiGene to Invest Hundreds of Millions of Dollars in US Manufacturing Site
$5.00
Available
Zenas, a US-China Biopharma, Announces $480 Million Deal for Autoimmune Therapy
$5.00
Available
CStone Out-Licenses China CTLA-4 Rights to Hengrui in $200 Million Deal
$5.00
Available
Apollomics Starts China Phase III Trial of Leukemia Drug
$5.00
Available
Livzon Out-licenses PD-1 to Bright Peak for PD-1 Targeted Immunocytokines
$5.00
Available
Connect Bio Reports Positive Data from Phase II Trial of Dermatitis Therapy
$5.00
Available
Clover Receives $38.9 Million CEPI Grant to Finish Development of COVID Vaccine
$5.00
Available
EdiGene Forms University Collaboration for RNA Edited Genetic Therapies
$5.00
Available
HebaBiz Approved to Start China Trial of Novel Hepatitis B Therapy
$5.00
Available
Shanghai AoHua Endoscope Raises $117 Million in IPO; Trades 71% Higher
$5.00
Available